Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATIONALE-15 PCV15 pneumococcal carriage challenge study
ISRCTN91656864Phase 4Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Jan 2025
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised, double-blind trial of pneumococcal 15-valent conjugate vaccine in pneumococcal disease (3 arms), sponsored by University of Oxford. Primary endpoint: Rate of experimental serotype 3 pneumococcal colonisation. Started Jan 2025; status: active, not recruiting.
02
Drugs
pneumococcal 15-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ISRCTN91656864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91656864.